Even if gastric cancer spreads to the abdominal cavity and becomes terminal, treatment should not be abandoned. A study found ...
Phase I study of recombinant interleukin-15 in combination with checkpoint inhibitors nivolumab and ipilimumab in subjects with refractory cancers. Background: The INSIGHT study evaluates feasibility ...